New Status Epilepticus Findings from New York Medical College Outlined (First-line infusion therapies in refractory status epilepticus: A retrospective comparison of outcomes between midazolam and propofol in 7446 patients)

Press/Media

Period28 Jan 2026

Media coverage

1

Media coverage

  • TitleNew Status Epilepticus Findings from New York Medical College Outlined (First-line infusion therapies in refractory status epilepticus: A retrospective comparison of outcomes between midazolam and propofol in 7446 patients)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date28/01/26
    PersonsSteven Wolf, Stephan Mayer